Industry

DUBLIN–(BUSINESS WIRE)–The “Europe Fabry Disease Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. This research provides comprehensive insights into Fabry Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Fabry Disease market size and drug sales. It also provides insights … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Upstream Bioprocessing Market Research Report by Product, Workflow, Use Type, Mode, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Upstream Bioprocessing Market size was estimated at USD 8,391.22 million in 2021 and expected to reach USD 9,471.18 million in 2022, and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Wearable Patch Market Research Report by Product (Blood Glucose Patch, Blood Oxygen Patch, and Blood Pressure Patch), Technology, Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Wearable Patch Market size … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Blood Group Typing Market Analysis by Product (Instruments, Consumables), by Techniques (Assay-Based Techniques, PCR-Based and Microarray Techniques), by Test Type (ABO Blood Tests, Antibody Screening, HLA Typing, Antigen Typing), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The blood group typing market size is estimated to be … [Read more…]

CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that, following the implementation of a one-for-thirty reverse stock split at 5:00 p.m. EDT today, the Company’s common stock will … [Read more…]

Remixed Version of Iconic “Plop Plop, Fizz Fizz” Jingle Celebrates Product Providing Relief for the Morning After WHIPPANY, N.J.–(BUSINESS WIRE)–Oh, what a relief it is! Alka-Seltzer®, the Bayer brand known for its effervescent antacid and pain relief products, today announced a partnership with musician and producer T-Pain to launch its newest innovation, NEW Alka-Seltzer Hangover … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Breath for Life, a non-profit organization established by a consortium of concerned medical and technical professionals and philanthropists, has now donated more than 2.4 million protective masks to other nonprofits and organizations and communities in need. As the US has continued to face uncertainty due to the COVID-19 pandemic, continued mask mandates have … [Read more…]

Many Suffered from Lack of Protections; Group Calls for Direct Relief FREMONT, Ohio–(BUSINESS WIRE)–As the COVID-19 pandemic continues to impact Ohioans, a new study from the Essential Ohio Coalition tells a story of the disproportionate impacts on essential workers since March 2020. The Essential Ohio coalition in collaboration with Cleveland State University published the Heroes … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Tissue Banking Market Size, Share & Trends Analysis Report, By Products (Equipment and Consumables & Media,) By Applications (Medical Research, Therapeutics, and Others), and Forecast 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global tissue banking market is anticipated to grow at a substantial CAGR of 9.3% during the forecast period. … [Read more…]

Say yes to the future of Correctional Healthcare HOUSTON–(BUSINESS WIRE)–YesCare today announced their Board of Advisors, who have been selected to reflect YesCare’s mission to build a recovery model of healthcare for correctional settings that mitigates risk for all stakeholders. The Board of Advisors include Tony C. Parker, Bill Lunsford, and Mark C. Fleming. “Our … [Read more…]